IKZF1 and acute lymphoblastic leukemia: Over 70% of Ph+ B-ALL patients harbor IKZF1 loss-of-function, usually resulting from mono-allelic deletions (bi-allelic deletions occur in 13–15% of cases [51,52]) or from the expression of dominant-negative isoforms, with the IK6 isoform being the most prevalent [53].